Last updated: August 5, 2025
Overview of Patent KR102522654
Patent KR102522654 pertains to a pharmaceutical invention filed in South Korea, focusing on a specific drug composition or formulation. While the precise title and detailed description may vary, such patents generally encompass compounds, formulations, or methods for treating particular conditions. For this analysis, we primarily examine the scope, claims, and patent landscape surrounding the patent to delineate its strategic importance and potential competitive environment.
Scope and Claims of KR102522654
Scope of the Patent
The scope of patent KR102522654 is defined by its claims, which determine the legal boundaries of the patent's protection. Most pharmaceutical patents, including those in South Korea, include independent claims that broadly cover a drug compound or composition, alongside dependent claims that specify particular embodiments or additional features.
1. Core Composition or Method of Use
The patent likely claims a novel chemical compound or a pharmaceutical composition comprising specific active ingredients. It may also claim a method of manufacturing or a method of treating certain diseases. Given common practices, the core invention probably revolves around:
- A novel molecular entity or a derivative.
- A specific formulation enhancing bioavailability or stability.
- A new combination of existing drugs for synergistic effects.
- A therapeutic method for a targeted condition, such as on chronic or infectious diseases.
2. Claims Hierarchy
- Independent Claims: Usually define the broadest scope, including the composition, compound, or method without limiting features.
- Dependent Claims: Narrower, specify particular features, such as dosage forms, specific chemical variants, or administration routes.
Claim Analysis
The crucial aspect of analysis lies in assessing how broad or narrow these claims are and their implications for patent rights.
- Chemical Composition Claims: These are likely to cover a specific molecular structure with certain substituents, structural features, or stereochemistry. Broad chemical claims may encompass a range of derivatives within a chemical class.
- Method-of-Use Claims: These may cover particular indications for the drug, such as treating a specific disease or condition.
- Manufacturing Claims: If present, they claim specific processes for producing the active ingredient or formulation, potentially as a way to extend patent protections.
Assessment:
The scope's strength hinges on claim language clarity—broad claims provide extensive protection but are more susceptible to invalidation if prior art exists, whereas narrow claims limit scope but offer stronger enforceability.
Patent Landscape and Strategic Context in South Korea
Patent Filing Trends and Lifecycle
South Korea’s robust pharmaceutical innovation landscape has been shaped by active patent filings, particularly by domestic large pharmaceutical firms (e.g., Samsung Biologics, Hanmi Science, and SK Biotek) and global entrants targeting the Korean market.
-
Filing Dynamics:
The patent was likely filed during the early 2010s or late 2000s, aligned with major innovations and research investments. Given the patent number, the filing probably occurred around 2012-2013, with a standard patent term of 20 years from the filing date.
-
Patent Family Expansion:
The patent could be part of a broader family, including counterparts in China, the US, Europe, and Japan. Patent families enable global protection for the core invention, avoiding regional patent gaps.
Patent Validity and Claims Strength
South Korean patent law adheres to the global standards under the Patent Act, requiring novelty, inventive step, and industrial applicability. The patent's enforceability depends on:
- Novelty over prior art, including previous Korean patents, scientific publications, and existing formulations.
- Inventive step, ensuring the invention is non-obvious.
- Detailed description, enabling skilled persons to manufacture or use the invention.
The patent's validity may be challenged if prior art anticipates the claims or if obvious modifications exist in the space.
Competitive Landscape
-
Major Competitors: Multinational pharmaceutical companies and local R&D firms actively filing patent applications in similar therapeutic areas likely coexist within this space.
-
Patent Defense Strategies: Patent holders typically monitor third-party filings and may file subsequent applications for improvements or formulations, creating a dense patent thicket to deter generic or biosimilar entry.
-
Potential Infringements: Given the broad claims, infringement risks are significant, especially if making similar formulations or mechanisms of action.
Legal and Commercial Implications
Patent Enforcement and Market Exclusivity
Patent KR102522654 grants exclusivity within South Korea, potentially safeguarding the core invention until expiry (generally 20 years from filing). The patent’s scope can influence:
- Litigation risks: Broad claims may lead to infringement lawsuits.
- Licensing opportunities: Companies seeking to commercialize similar treatments may license the patent.
- Market positioning: The patent strengthens the holder's bargaining power against generic entrants.
M&A and Investment Climate
Patent rights such as KR102522654 attract mergers, acquisitions, or collaborative investments, especially if aligned with blockbuster products or treatments for high-demand diseases like oncology, autoimmune disorders, or infectious diseases.
Conclusion and Strategic Insights
- Rigorous Claim Drafting is Vital: The strength of the patent hinges on the specificity and clarity of claims, balancing broad protection with validity.
- Patent Landscape Should Be Monitored: Continuous surveillance for competing filings and prior art is essential to maintain enforceability.
- Leverage Patent for Commercial Advantage: The patent provides a competitive moat; strategic licensing, litigation, or partnership decisions should leverage its scope.
- Global Portfolio Development: Extending protection through international filings enhances market reach and legal standing.
Key Takeaways
- Broad yet defensible claims are critical for maximizing patent life and market exclusivity.
- Active patent landscape monitoring can prevent infringement issues and identify licensing opportunities.
- Patent KR102522654’s scope likely covers a specific drug compound or formulation, with implications for competitive positioning.
- Validity depends heavily on prior art and claim interpretation; ongoing patent prosecution or defenses may be necessary.
- Commercial success depends on integrating patent strategy into overall drug development, manufacturing, and market penetration plans.
FAQs
1. What is the typical lifespan of the patent KR102522654 in South Korea?
Standard patent protection lasts 20 years from the filing date, subject to maintenance fees and legal challenges.
2. Can competing companies develop similar drugs without infringing on KR102522654?
If they design around the patent claims—such as using different chemical structures or formulations—they can avoid infringement, provided their innovation does not breach claims.
3. Is it possible to challenge the validity of KR102522654 in South Korea?
Yes, third parties can file a patent invalidation action if they believe prior art invalidates the patent’s novelty or inventive step.
4. How does KR102522654 compare to international patents?
It may be part of a patent family covering multiple jurisdictions. Typically, companies file global patent applications (via PCT or direct filings) to extend protection.
5. What strategies should patent holders adopt to maximize the value of KR102522654?
Holder should maintain and defend the patent vigorously, seek extensions via patent term adjustments if applicable, and consider licensing or partnering to monetize the patent.
References
[1] South Korea Patent Act, Legal Framework for Pharmaceuticals and Patents.
[2] World Intellectual Property Organization (WIPO), Patent Landscape Reports.
[3] Korean Intellectual Property Office (KIPO), Guidelines and Patent Examination Standards.
